These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 15831806

  • 1. ACAT2 is a target for treatment of coronary heart disease associated with hypercholesterolemia.
    Rudel LL, Lee RG, Parini P.
    Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1112-8. PubMed ID: 15831806
    [Abstract] [Full Text] [Related]

  • 2. Discovery and combinatorial synthesis of fungal metabolites beauveriolides, novel antiatherosclerotic agents.
    Tomoda H, Doi T.
    Acc Chem Res; 2008 Jan; 41(1):32-9. PubMed ID: 17803269
    [Abstract] [Full Text] [Related]

  • 3. ACAT2 is localized to hepatocytes and is the major cholesterol-esterifying enzyme in human liver.
    Parini P, Davis M, Lada AT, Erickson SK, Wright TL, Gustafsson U, Sahlin S, Einarsson C, Eriksson M, Angelin B, Tomoda H, Omura S, Willingham MC, Rudel LL.
    Circulation; 2004 Oct 05; 110(14):2017-23. PubMed ID: 15451793
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Identification of ACAT1- and ACAT2-specific inhibitors using a novel, cell-based fluorescence assay: individual ACAT uniqueness.
    Lada AT, Davis M, Kent C, Chapman J, Tomoda H, Omura S, Rudel LL.
    J Lipid Res; 2004 Feb 05; 45(2):378-86. PubMed ID: 14617738
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Expression levels of ACAT1 and ACAT2 genes in the liver and intestine of baboons with high and low lipemic responses to dietary lipids.
    Kushwaha RS, Rosillo A, Rodriguez R, McGill HC.
    J Nutr Biochem; 2005 Dec 05; 16(12):714-21. PubMed ID: 16081263
    [Abstract] [Full Text] [Related]

  • 8. Androgen-mediated cholesterol metabolism in LNCaP and PC-3 cell lines is regulated through two different isoforms of acyl-coenzyme A:Cholesterol Acyltransferase (ACAT).
    Locke JA, Wasan KM, Nelson CC, Guns ES, Leon CG.
    Prostate; 2008 Jan 01; 68(1):20-33. PubMed ID: 18000807
    [Abstract] [Full Text] [Related]

  • 9. Cholesterol regulates ACAT2 gene expression and enzyme activity in human hepatoma cells.
    Pramfalk C, Angelin B, Eriksson M, Parini P.
    Biochem Biophys Res Commun; 2007 Dec 14; 364(2):402-9. PubMed ID: 17950700
    [Abstract] [Full Text] [Related]

  • 10. Acyl coenzyme A: cholesterol acyltransferase types 1 and 2: structure and function in atherosclerosis.
    Rudel LL, Lee RG, Cockman TL.
    Curr Opin Lipidol; 2001 Apr 14; 12(2):121-7. PubMed ID: 11264983
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of acyl-CoA cholesterol acyltransferase by F12511 (Eflucimibe): could it be a new antiatherosclerotic therapeutic?
    López-Farré AJ, Sacristán D, Zamorano-León JJ, San-Martín N, Macaya C.
    Cardiovasc Ther; 2008 Apr 14; 26(1):65-74. PubMed ID: 18466422
    [Abstract] [Full Text] [Related]

  • 12. Compared with Acyl-CoA:cholesterol O-acyltransferase (ACAT) 1 and lecithin:cholesterol acyltransferase, ACAT2 displays the greatest capacity to differentiate cholesterol from sitosterol.
    Temel RE, Gebre AK, Parks JS, Rudel LL.
    J Biol Chem; 2003 Nov 28; 278(48):47594-601. PubMed ID: 12975367
    [Abstract] [Full Text] [Related]

  • 13. Acyl-coenzyme A:cholesterol acyltransferase inhibitors for controlling hypercholesterolemia and atherosclerosis.
    Miyazaki A, Sakai M, Sakamoto Y, Horiuchi S.
    Curr Opin Investig Drugs; 2003 Sep 28; 4(9):1095-9. PubMed ID: 14582454
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Selectivity of microbial acyl-CoA: cholesterol acyltransferase inhibitors toward isozymes.
    Ohshiro T, Rudel LL, Omura S, Tomoda H.
    J Antibiot (Tokyo); 2007 Jan 28; 60(1):43-51. PubMed ID: 17390588
    [Abstract] [Full Text] [Related]

  • 16. Potential role of acyl-coenzyme A:cholesterol transferase (ACAT) Inhibitors as hypolipidemic and antiatherosclerosis drugs.
    Leon C, Hill JS, Wasan KM.
    Pharm Res; 2005 Oct 28; 22(10):1578-88. PubMed ID: 16180116
    [Abstract] [Full Text] [Related]

  • 17. Importance of acyl-coenzyme A:cholesterol acyltransferase 1/2 dual inhibition for anti-atherosclerotic potency of pactimibe.
    Kitayama K, Tanimoto T, Koga T, Terasaka N, Fujioka T, Inaba T.
    Eur J Pharmacol; 2006 Jul 01; 540(1-3):121-30. PubMed ID: 16730694
    [Abstract] [Full Text] [Related]

  • 18. Isoform-specific inhibitors of ACATs: recent advances and promising developments.
    Ohshiro T, Tomoda H.
    Future Med Chem; 2011 Dec 01; 3(16):2039-61. PubMed ID: 22098352
    [Abstract] [Full Text] [Related]

  • 19. Liver-specific inhibition of acyl-coenzyme a:cholesterol acyltransferase 2 with antisense oligonucleotides limits atherosclerosis development in apolipoprotein B100-only low-density lipoprotein receptor-/- mice.
    Bell TA, Brown JM, Graham MJ, Lemonidis KM, Crooke RM, Rudel LL.
    Arterioscler Thromb Vasc Biol; 2006 Aug 01; 26(8):1814-20. PubMed ID: 16675724
    [Abstract] [Full Text] [Related]

  • 20. Differential modulation of ACAT1 and ACAT2 transcription and activity by long chain free fatty acids in cultured cells.
    Seo T, Oelkers PM, Giattina MR, Worgall TS, Sturley SL, Deckelbaum RJ.
    Biochemistry; 2001 Apr 17; 40(15):4756-62. PubMed ID: 11294643
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.